RGS5 and neoplasm: Immune evasion directed by RGS-5 tumor-derived pericytes has been further explored in B16F10 mass treated with a natural immunomodulator (neem leaf glycoprotein, NLGP) reported to normalize the vasculature in the TME (Banerjee et al., 2014).